Treatment of class II furcation defects using porous hydroxylapatite in conjunction with a polytetrafluoroethylene membrane.
The purpose of the present study was to determine whether the use of a porous hydroxylapatite in conjunction with guided tissue regeneration technique influenced the clinical results in the treatment of Class II furcation defects in humans. Fifteen subjects with a mean age of 39.4 +/- 9.3 years were used in this study. All subjects had Class II furcation defects on the buccal surfaces of 2 lower molars. In each subject one furcation defect was filled with granular porous hydroxylapatite and then a barrier of polytetrafluoroethylene periodontal material was positioned over the furcation. The other furca was treated in the same manner except that no hydroxylapatite was used. The flaps were placed coronally to their presurgical level. Before the surgery and 6 months postsurgery all areas were clinically evaluated using the same clinical parameters. Reentry procedures were used to repeat measurements of the osseous defects made during the initial surgery. At 6 months both surgical procedures resulted in statistically significant reduction in pocket depth and gain in probing attachment level with no significant difference between the two surgical procedures. When porous hydroxylapatite was used in conjunction with a polytetrafluoroethylene membrane, however, less gingival recession and more defect fill were obtained. This study suggests that there is a difference in healing of molar furcations when porous hydroxylapatite is used in conjunction with a barrier membrane. The lesions treated with porous hydroxylapatite gain in clinical attachment and horizontal and vertical bone fill, while the lesions treated with membrane only gain probing attachment with less bony fill.
Lekovic
V
V
University of Belgrade School of Dentistry, Yugoslavia.
Kenney
E B
EB
Carranza
F A
FA
Danilovic
V
V
D000328:Adult; D016301:Alveolar Bone Loss / Q000601:surgery; D000539:Alveolar Process / Q000033:anatomy & histology / Q000502:physiology; D017886:Durapatite; D005260:Female; D005500:Follow-Up Studies; D005881:Gingiva / Q000033:anatomy & histology / Q000502:physiology; D006801:Humans; D006882:Hydroxyapatites; D008297:Male; D008567:Membranes, Artificial; D008963:Molar; D010510:Periodontal Diseases / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D011138:Polytetrafluoroethylene; D019736:Prostheses and Implants; D012038:Regeneration; D013524:Surgical Flaps; D014092:Tooth Root / Q000601:surgery
D006882:Hydroxyapatites; D008567:Membranes, Artificial; D011138:Polytetrafluoroethylene; D017886:Durapatite